Pharmaceutical/Biotech

U.S. Booster Push Is Fresh Challenge for Healthcare Providers

August 25, 2021

As the Biden administration moved last week to make COVID-19 booster shots available for many U.S. adults, health-care providers are preparing for a fresh pandemic battle: getting uncertain or confused patients to take another dose.

Counterfeit Goods Are Everywhere. This Technology Sweeps Them From Supply Chains.

August 24, 2021

Benjamin Kiunisala, SCB Contributor

The counterfeit drug market alone costs more than $200 billion per year — enough to bring 13 new drugs to market.

Wednesday, Sep 15, 2021

How to Partner with Impact-Led Social Enterprises in Your Supply Chain

August 19, 2021

Avetta

Companies across industries are looking for ways to make their supply chains more sustainable, resilient, and socially responsible. Social enterprises can be valuable partners in achieving these goals.

The Winners and Losers in the Bipartisan Infrastructure Bill

August 3, 2021

Bloomberg

A Senate plan to spend $550 billion on U.S. infrastructure stands to benefit industries heavily dependent on transportation, with companies including Amazon.com Inc., FedEx Corp. and Comcast Corp. among the biggest winners.

Covid Vaccine Makers Take Aim at Bottlenecks to Speed Production

July 20, 2021

Bloomberg

A new initiative aims to overcome bottlenecks that have hampered the production and global rollout of COVID-19 shots, linking manufacturers with suppliers of vital materials.

How Fujifilm’s Pivot to Health Care, Chips Paid Off in the Pandemic

July 15, 2021

Bloomberg

Fujifilm Holdings Corp.’s tough decision to accept the demise of its film and digital photography businesses and embrace the health care and semiconductor sectors was validated last year.

VIDEO

Watch: Will Biden’s Task Force Bring Manufacturing Back to the U.S.?

July 13, 2021

Robert J. Bowman, SupplyChainBrain

Kristi Zentner and Heather Marx, attorneys in the Customs, Imports & Trade Remedies Practice Group of Cozen O’Connor, discuss how the recommendations of Biden’s supply chain task force might lead to real progress toward the return of domestic manufacturing of critical supplies.

VIDEO

Watch: What to Do About the Vaccine Surplus in the U.S.

June 28, 2021

Robert J. Bowman, SupplyChainBrain

Suresh Acharya, Professor of Practice in the Robert H. Smith School of Business at the University of Maryland, addresses the excess of COVID-19 vaccine doses in the U.S., and what to do about it.

Vaccine Shortages Hit Global Supply Program, Halting Rollouts

June 23, 2021

Bloomberg

A string of nations across Africa and Asia have run out of COVID-19 vaccines or are on the brink of doing so, months after receiving first shipments from a global program meant to equitably distribute the lifesaving shots.

AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand

June 21, 2021

Bloomberg

AstraZeneca Plc’s COVID-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback for a shot that was meant to be the backbone of the global inoculation effort.

Pharmaceutical/Biotech

The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.